Switch theme
Sign up to access all valuation multiples
Changchun High-Tech Industry (Group) Co Ltd is engaged in the production and sales of biopharmaceuticals, Chinese patent medicine production, and real estate development.
1993
2.1K+
LTM Revenue $1.9B
LTM EBITDA $478M
$5.3B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Changchun High-Tech has a last 12-month revenue (LTM) of $1.9B and a last 12-month EBITDA of $478M.
In the most recent fiscal year, Changchun High-Tech achieved revenue of $1.9B and an EBITDA of $527M.
Changchun High-Tech expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Changchun High-Tech valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $1.9B | XXX | $1.9B | XXX | XXX | XXX |
| Gross Profit | $1.6B | XXX | $1.6B | XXX | XXX | XXX |
| Gross Margin | 85% | XXX | 86% | XXX | XXX | XXX |
| EBITDA | $478M | XXX | $527M | XXX | XXX | XXX |
| EBITDA Margin | 25% | XXX | 28% | XXX | XXX | XXX |
| EBIT | $451M | XXX | $512M | XXX | XXX | XXX |
| EBIT Margin | 24% | XXX | 27% | XXX | XXX | XXX |
| Net Profit | $356M | XXX | $359M | XXX | XXX | XXX |
| Net Margin | 19% | XXX | 19% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of May 30, 2025, Changchun High-Tech's stock price is CNY 105 (or $15).
Changchun High-Tech has current market cap of CNY 42.7B (or $5.9B), and EV of CNY 38.4B (or $5.3B).
See Changchun High-Tech trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $5.3B | $5.9B | XXX | XXX | XXX | XXX | $0.87 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialAs of May 30, 2025, Changchun High-Tech has market cap of $5.9B and EV of $5.3B.
Changchun High-Tech's trades at 2.8x EV/Revenue multiple, and 10.1x EV/EBITDA.
Equity research analysts estimate Changchun High-Tech's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Changchun High-Tech has a P/E ratio of 16.6x.
See valuation multiples for Changchun High-Tech and 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $5.9B | XXX | $5.9B | XXX | XXX | XXX |
| EV (current) | $5.3B | XXX | $5.3B | XXX | XXX | XXX |
| EV/Revenue | 2.8x | XXX | 2.8x | XXX | XXX | XXX |
| EV/EBITDA | 11.1x | XXX | 10.1x | XXX | XXX | XXX |
| EV/EBIT | 11.8x | XXX | 10.4x | XXX | XXX | XXX |
| EV/Gross Profit | 3.3x | XXX | n/a | XXX | XXX | XXX |
| P/E | 16.6x | XXX | 16.5x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | 41.5x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialChangchun High-Tech's last 12 month revenue growth is 5%
Changchun High-Tech's revenue per employee in the last FY averaged $0.9M, while opex per employee averaged $0.5M for the same period.
Changchun High-Tech's rule of 40 is 47% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Changchun High-Tech's rule of X is 38% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Changchun High-Tech and other 12K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 5% | XXX | 5% | XXX | XXX | XXX |
| EBITDA Margin | 25% | XXX | 28% | XXX | XXX | XXX |
| EBITDA Growth | -4% | XXX | -28% | XXX | XXX | XXX |
| Rule of 40 | 47% | XXX | 33% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 38% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.9M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.5M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | 23% | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 16% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 58% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Julphar | XXX | XXX | XXX | XXX | XXX | XXX |
| Galapagos | XXX | XXX | XXX | XXX | XXX | XXX |
| Pharming | XXX | XXX | XXX | XXX | XXX | XXX |
| Vivoryon Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| Armata Pharmaceuticals | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Changchun High-Tech acquired XXX companies to date.
Last acquisition by Changchun High-Tech was XXXXXXXX, XXXXX XXXXX XXXXXX . Changchun High-Tech acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Start Free Trial| When was Changchun High-Tech founded? | Changchun High-Tech was founded in 1993. |
| Where is Changchun High-Tech headquartered? | Changchun High-Tech is headquartered in China. |
| How many employees does Changchun High-Tech have? | As of today, Changchun High-Tech has 2.1K+ employees. |
| Is Changchun High-Tech publicy listed? | Yes, Changchun High-Tech is a public company listed on SHE. |
| What is the stock symbol of Changchun High-Tech? | Changchun High-Tech trades under 000661 ticker. |
| When did Changchun High-Tech go public? | Changchun High-Tech went public in 1996. |
| Who are competitors of Changchun High-Tech? | Similar companies to Changchun High-Tech include e.g. Julphar, Galapagos, Pharming, Vivoryon Therapeutics. |
| What is the current market cap of Changchun High-Tech? | Changchun High-Tech's current market cap is $5.9B |
| What is the current revenue of Changchun High-Tech? | Changchun High-Tech's last 12 months revenue is $1.9B. |
| What is the current revenue growth of Changchun High-Tech? | Changchun High-Tech revenue growth (NTM/LTM) is 5%. |
| What is the current EV/Revenue multiple of Changchun High-Tech? | Current revenue multiple of Changchun High-Tech is 2.8x. |
| Is Changchun High-Tech profitable? | Yes, Changchun High-Tech is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Changchun High-Tech? | Changchun High-Tech's last 12 months EBITDA is $478M. |
| What is Changchun High-Tech's EBITDA margin? | Changchun High-Tech's last 12 months EBITDA margin is 25%. |
| What is the current EV/EBITDA multiple of Changchun High-Tech? | Current EBITDA multiple of Changchun High-Tech is 11.1x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
